These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 2632215

  • 1. Comparative antimicrobial activities of ribostamycin, gentamicin, ampicillin and lincomycin in vitro and in vivo.
    Inouye S, Watanabe T, Kitasato I.
    Drugs Exp Clin Res; 1989; 15(10):465-76. PubMed ID: 2632215
    [Abstract] [Full Text] [Related]

  • 2. [Data on the effectiveness of a new aminoglycoside antibiotic in the treatment of urinary tract infections].
    Trischitta C, Urso G, Caruso L, Calcara G.
    Minerva Urol; 1980; 32(1):49-58. PubMed ID: 7382968
    [No Abstract] [Full Text] [Related]

  • 3. [Ribostamycin in chronic and recurrent bronchopulmonary and urinary infections].
    Abate G, Polimeni RM, Visani G.
    Minerva Med; 1980 Feb 11; 71(4):279-85. PubMed ID: 7354947
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo activities of DW-224a, a novel fluoroquinolone antibiotic agent.
    Kwon AR, Min YH, Ryu JM, Choi DR, Shim MJ, Choi EC.
    J Antimicrob Chemother; 2006 Sep 11; 58(3):684-8. PubMed ID: 16873394
    [Abstract] [Full Text] [Related]

  • 5. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A, Stefani S, Caccamo F, Nicolosi VM, Nicoletti G.
    Chemioterapia; 1987 Feb 11; 6(1):17-22. PubMed ID: 3470153
    [Abstract] [Full Text] [Related]

  • 6. Serious bacterial infections in hospitalized febrile infants aged 90 days or younger: the traditional combination of ampicillin and gentamicin is still appropriate.
    Ashkenazi-Hoffnung L, Livni G, Amir J, Bilavsky E.
    Scand J Infect Dis; 2011 Jul 11; 43(6-7):489-94. PubMed ID: 21351817
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of dactimicin and other aminoglycosides against bacteria producing aminoglycoside-modifying enzymes.
    Felmingham D, Jones K.
    Drugs Exp Clin Res; 1989 Jul 11; 15(3):133-6. PubMed ID: 2752913
    [Abstract] [Full Text] [Related]

  • 8. In vitro antibacterial activity of enoxacin, a new pyridonecarboxylic acid.
    Fabio U, Bondi M, Galletti F, Manicardi G, Messi P, Neglia R, Casolari C.
    Boll Ist Sieroter Milan; 1987 Jul 11; 66(2):110-5. PubMed ID: 3478050
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic use in neonatal sepsis.
    Yurdakök M.
    Turk J Pediatr; 1998 Jul 11; 40(1):17-33. PubMed ID: 9722468
    [Abstract] [Full Text] [Related]

  • 10. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN, Huynh HK, Biedenbach DJ, Fritsche TR, Sader HS.
    J Antimicrob Chemother; 2004 Jul 11; 54(1):144-54. PubMed ID: 15190031
    [Abstract] [Full Text] [Related]

  • 11. Lincomycin, clindamycin and their applications.
    Spízek J, Rezanka T.
    Appl Microbiol Biotechnol; 2004 May 11; 64(4):455-64. PubMed ID: 14762701
    [Abstract] [Full Text] [Related]

  • 12. Enzymatic modification of aminoglycoside antibiotics in gentamicin-resistant gram-negative bacteria.
    Kettner M, Navarová J, Lebek G, Krcméry V.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug 11; 257(3):372-82. PubMed ID: 6091367
    [Abstract] [Full Text] [Related]

  • 13. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY, Chang SC, Hsueh PR, Feng NH, Wang JT.
    J Microbiol Immunol Infect; 2007 Dec 11; 40(6):481-6. PubMed ID: 18087627
    [Abstract] [Full Text] [Related]

  • 14. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD.
    Dan Med Bull; 2000 Nov 11; 47(5):313-27. PubMed ID: 11155659
    [Abstract] [Full Text] [Related]

  • 15. Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity.
    Jones RN.
    J Chemother; 1995 Jun 11; 7 Suppl 2():7-16. PubMed ID: 8622113
    [Abstract] [Full Text] [Related]

  • 16. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
    Speciale A, Stefani S, Caccamo F, Nicolosi VM, Nicoletti G.
    Drugs Exp Clin Res; 1987 Jun 11; 13(9):555-61. PubMed ID: 3480796
    [Abstract] [Full Text] [Related]

  • 17. Susceptibility of clinical isolates to dactimicin and gentamicin.
    Bergan T.
    Drugs Exp Clin Res; 1989 Jun 11; 15(3):109-12. PubMed ID: 2752907
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
    Debbia E, Schito GC, Nicoletti G, Speciale A.
    Chemioterapia; 1987 Oct 11; 6(5):319-23. PubMed ID: 3480779
    [Abstract] [Full Text] [Related]

  • 19. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
    Kaczmarska L, Jakoniuk P.
    Med Dosw Mikrobiol; 2003 Oct 11; 55(1):1-10. PubMed ID: 12908409
    [Abstract] [Full Text] [Related]

  • 20. Preclinical comparative evaluation of aminoglycosides.
    Abbate GF, Alagia I, Giaquinto E, Giordano B, Leonessa V, Altucci P.
    Chemioterapia; 1984 Dec 11; 3(6):378-84. PubMed ID: 6529780
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.